1. Home
  2. PVH vs MIRM Comparison

PVH vs MIRM Comparison

Compare PVH & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PVH Corp.

PVH

PVH Corp.

HOLD

Current Price

$60.86

Market Cap

3.2B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$90.66

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVH
MIRM
Founded
1881
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
5.4B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
PVH
MIRM
Price
$60.86
$90.66
Analyst Decision
Buy
Strong Buy
Analyst Count
16
12
Target Price
$89.80
$114.67
AVG Volume (30 Days)
720.6K
688.0K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
0.24%
N/A
EPS Growth
N/A
74.59
EPS
3.72
N/A
Revenue
$8,652,900,000.00
$19,138,000.00
Revenue This Year
$3.64
$24.61
Revenue Next Year
$1.84
$21.75
P/E Ratio
$16.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.28
$36.88
52 Week High
$89.79
$109.28

Technical Indicators

Market Signals
Indicator
PVH
MIRM
Relative Strength Index (RSI) 32.15 43.51
Support Level N/A $85.76
Resistance Level $88.24 $107.51
Average True Range (ATR) 2.02 4.07
MACD -0.85 -0.94
Stochastic Oscillator 10.68 19.09

Price Performance

Historical Comparison
PVH
MIRM

About PVH PVH Corp.

PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: